Schedule 13D ownership disclosure

ESSA PHARMA INC

Common Shares · CUSIP: 29668H708

Event date: 2025-04-24

Filing-level shares
4,221,546
Percent of class
9.5%
  • BML Investment Partners, L.P.Reported CIK 0001373604

    Shares: 4,221,546 · Class: 9.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001373604-25-000063
Form type
SCHEDULE 13D
Filer
BML Investment Partners, L.P.
CIK
CIK 1373604
Filed
Apr 24, 2025
Reporting period
Apr 24, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub